274 related articles for article (PubMed ID: 26199140)
21. Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer.
Zhang X; Liu D; Li M; Cao C; Wan D; Xi B; Li W; Tan J; Wang J; Wu Z; Ma D; Gao Q
J Hematol Oncol; 2017 Jan; 10(1):29. PubMed ID: 28114995
[TBL] [Abstract][Full Text] [Related]
22. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer.
Zhang Z; Yang C; Gao W; Chen T; Qian T; Hu J; Tan Y
Cancer Lett; 2015 Jun; 361(2):240-50. PubMed ID: 25779673
[TBL] [Abstract][Full Text] [Related]
23. Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer.
Dong C; Yuan T; Wu Y; Wang Y; Fan TW; Miriyala S; Lin Y; Yao J; Shi J; Kang T; Lorkiewicz P; St Clair D; Hung MC; Evers BM; Zhou BP
Cancer Cell; 2013 Mar; 23(3):316-31. PubMed ID: 23453623
[TBL] [Abstract][Full Text] [Related]
24. DOT1L inhibition blocks multiple myeloma cell proliferation by suppressing IRF4-MYC signaling.
Ishiguro K; Kitajima H; Niinuma T; Ishida T; Maruyama R; Ikeda H; Hayashi T; Sasaki H; Wakasugi H; Nishiyama K; Shindo T; Yamamoto E; Kai M; Sasaki Y; Tokino T; Nakase H; Suzuki H
Haematologica; 2019 Jan; 104(1):155-165. PubMed ID: 30171029
[TBL] [Abstract][Full Text] [Related]
25. MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state.
Poli V; Fagnocchi L; Fasciani A; Cherubini A; Mazzoleni S; Ferrillo S; Miluzio A; Gaudioso G; Vaira V; Turdo A; Gaggianesi M; Chinnici A; Lipari E; Bicciato S; Bosari S; Todaro M; Zippo A
Nat Commun; 2018 Mar; 9(1):1024. PubMed ID: 29523784
[TBL] [Abstract][Full Text] [Related]
26. Simian virus 40 large T overcomes p300 repression of c-Myc.
Singhal G; Kadeppagari RK; Sankar N; Thimmapaya B
Virology; 2008 Aug; 377(2):227-32. PubMed ID: 18570961
[TBL] [Abstract][Full Text] [Related]
27. Targeting Histone Methyltransferase DOT1L by a Novel Psammaplin A Analog Inhibits Growth and Metastasis of Triple-Negative Breast Cancer.
Byun WS; Kim WK; Han HJ; Chung HJ; Jang K; Kim HS; Kim S; Kim D; Bae ES; Park S; Lee J; Park HG; Lee SK
Mol Ther Oncolytics; 2019 Dec; 15():140-152. PubMed ID: 31720371
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of DOT1L by Half-Selenopsammaplin A Analogs Suppresses Tumor Growth and EMT-Mediated Metastasis in Triple-Negative Breast Cancer.
Byun WS; Lee GH; Park HG; Lee SK
Pharmaceuticals (Basel); 2020 Dec; 14(1):. PubMed ID: 33379275
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional factors p300 and MRTF-A synergistically enhance the expression of migration-related genes in MCF-7 breast cancer cells.
He H; Wang D; Yao H; Wei Z; Lai Y; Hu J; Liu X; Wang Y; Zhou H; Wang N; Luo XG; Zhang TC
Biochem Biophys Res Commun; 2015 Nov; 467(4):813-20. PubMed ID: 26476216
[TBL] [Abstract][Full Text] [Related]
30. Somatic polyploidy is associated with the upregulation of c-MYC interacting genes and EMT-like signature.
Vazquez-Martin A; Anatskaya OV; Giuliani A; Erenpreisa J; Huang S; Salmina K; Inashkina I; Huna A; Nikolsky NN; Vinogradov AE
Oncotarget; 2016 Nov; 7(46):75235-75260. PubMed ID: 27655693
[TBL] [Abstract][Full Text] [Related]
31. Aspirin cooperates with p300 to activate the acetylation of H3K9 and promote FasL-mediated apoptosis of cancer stem-like cells in colorectal cancer.
Chen Z; Li W; Qiu F; Huang Q; Jiang Z; Ye J; Cheng P; Low C; Guo Y; Yi X; Chen W; Yu Y; Han Y; Wu J; Jin S; Kong D; Huang J
Theranostics; 2018; 8(16):4447-4461. PubMed ID: 30214631
[TBL] [Abstract][Full Text] [Related]
32. TPO-Induced Metabolic Reprogramming Drives Liver Metastasis of Colorectal Cancer CD110+ Tumor-Initiating Cells.
Wu Z; Wei D; Gao W; Xu Y; Hu Z; Ma Z; Gao C; Zhu X; Li Q
Cell Stem Cell; 2015 Jul; 17(1):47-59. PubMed ID: 26140605
[TBL] [Abstract][Full Text] [Related]
33. MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis.
Meškytė EM; Keskas S; Ciribilli Y
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081056
[TBL] [Abstract][Full Text] [Related]
34. MYC leads the way.
Venkateswaran N; Conacci-Sorrell M
Small GTPases; 2020 Mar; 11(2):86-94. PubMed ID: 29173017
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA 675 cooperates PKM2 to aggravate progression of human liver cancer stem cells induced from embryonic stem cells.
Yang Y; Meng Q; Wang C; Li X; Lu Y; Xin X; Zheng Q; Lu D
J Mol Med (Berl); 2018 Oct; 96(10):1119-1130. PubMed ID: 30140938
[TBL] [Abstract][Full Text] [Related]
36. MYC dysfunction modulates stemness and tumorigenesis in breast cancer.
Liu Y; Zhu C; Tang L; Chen Q; Guan N; Xu K; Guan X
Int J Biol Sci; 2021; 17(1):178-187. PubMed ID: 33390842
[TBL] [Abstract][Full Text] [Related]
37. Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cells.
Cui B; Luo Y; Tian P; Peng F; Lu J; Yang Y; Su Q; Liu B; Yu J; Luo X; Yin L; Cheng W; An F; He B; Liang D; Wu S; Chu P; Song L; Liu X; Luo H; Xu J; Pan Y; Wang Y; Li D; Huang P; Yang Q; Zhang L; Zhou BP; Liu S; Xu G; Lam EW; Kelley KW; Liu Q
J Clin Invest; 2019 Mar; 129(3):1030-1046. PubMed ID: 30688660
[TBL] [Abstract][Full Text] [Related]
38. DOT1L stimulates MYC/Mondo transcription factor activity by promoting its degradation cycle on chromatin.
Sepulveda GP; Gushchanskaia ES; Mora-Martin A; Esse R; Nikorich I; Ceballos A; Kwan J; Blum BC; Dholiya P; Emili A; Perissi V; Cardamone MD; Grishok A
bioRxiv; 2024 Feb; ():. PubMed ID: 38370658
[TBL] [Abstract][Full Text] [Related]
39. Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer.
Cieśla M; Ngoc PCT; Cordero E; Martinez ÁS; Morsing M; Muthukumar S; Beneventi G; Madej M; Munita R; Jönsson T; Lövgren K; Ebbesson A; Nodin B; Hedenfalk I; Jirström K; Vallon-Christersson J; Honeth G; Staaf J; Incarnato D; Pietras K; Bosch A; Bellodi C
Mol Cell; 2021 Apr; 81(7):1453-1468.e12. PubMed ID: 33662273
[TBL] [Abstract][Full Text] [Related]
40. DOT1L promotes cell proliferation and invasion by epigenetically regulating STAT5B in renal cell carcinoma.
Hou Y; Huang S; Liu J; Wang L; Yuan Y; Liu H; Weng X; Chen Z; Hu J; Liu X
Am J Cancer Res; 2023; 13(1):276-292. PubMed ID: 36777512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
